Alira Health Partners with Policy Matters to Foster Market Access in the UK
The partnership strengthens the company’s global consulting services throughout its presence in Northern Europe.
Alira Health, a global advisory and clinical research firm whose mission is to humanize healthcare and life sciences, announces its partnership with leading UK market access specialist consultancy Policy Matters. Policy Matters is an independent consultancy offering end-to-end market access solutions. The Alira Health and Policy Matters partnership allows Alira Health to reach clients based in the UK through dedicated regional projects while fostering the company’s global market access solutions through the expertise of one of the most experienced local access companies in the UK.
About Alira Health
Alira Health is a global advisory and clinical research firm whose mission is to humanize healthcare and life sciences, in partnership with patients, through innovative technologies and expert guidance. From development to medical care, Alira Health complements the expertise of its Pharma, Biotech, and MedTech clients with a full spectrum of services across their entire solutions lifecycle.
Learn more: www.alirahealth.com
About Policy Matters
Policy Matters is an independent UK based market access and healthcare policy consultancy offering dynamic and effective bespoke, integrated access strategies, based on their exceptional understanding of the constantly evolving UK healthcare and access environment. They focus on companies that develop and supply medicines, technologies, devices, and services to UK National Health Service (NHS) organizations.
Learn more: www.policy-matters.com
Alira Health CEO Gabriele Brambilla Interviewed by Investment Reports
Alira Health’s Renee Willmon and MG Registry featured in new Rare Disease Article Series
The MedTech World Podcast: Interview with Gabriele Brambilla
The State of Market Access in Italy 2023
MGFA National Patient Conference 2023
WIRED Health 2023
World EPA Congress 2023
Subscribe to our newsletter for the latest news, events, and thought leadership